Halozyme to buy Elektrofi for more than $750M (HALO:NASDAQ)

Core Insights - Halozyme Therapeutics has announced the acquisition of Elektrofi, Inc. for an upfront payment of $750 million, with additional milestone payments expected [2] Company Summary - The acquisition is focused on enhancing drug delivery technology, which is a strategic move for Halozyme Therapeutics [2] - The deal is anticipated to close in the fourth quarter of the year [2]